Palisade Bio (PALI) Depreciation & Amortization (CF) (2010 - 2025)
Palisade Bio (PALI) reported Depreciation & Amortization (CF) of $1000.0 for Q3 2025, little changed year-over-year from $1000.0 in Q3 2024, and little changed quarter-over-quarter from $1000.0 in Q2 2025.
Palisade Bio (PALI) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Palisade Bio (PALI) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $1000.0 in Q3 2025.
- Depreciation & Amortization (CF) for Q3 2025 came in at $1000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2000.0 (down 33.33% YoY), and the FY2025 annual result was $3000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) held at $1000.0 in Q3 2025 per PALI's latest filing, from $1000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $2000.0 in Q4 2022 and troughed at $1000.0 in Q1 2021.
- A 5-year average of $1153.8 and a median of $1000.0 in 2021 frame the typical range for Depreciation & Amortization (CF).
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 103.56% in 2021 and fell as far as 96.56% in 2021.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $1000.0 in 2021, then jumped by 100.0% to $2000.0 in 2022, then sank by 50.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- Business Quant data shows PALI's Depreciation & Amortization (CF) at $1000.0 in Q3 2025, $1000.0 in Q2 2025, and $1000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |